IperionX (NASDAQ:IPX – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at Roth Mkm in a report issued on Tuesday,Benzinga reports. They currently have a $74.00 price objective on the stock. Roth Mkm’s price objective suggests a potential upside of 42.69% from the stock’s current price.
Other equities research analysts also recently issued reports about the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of IperionX in a research report on Wednesday, October 8th. Wall Street Zen downgraded IperionX from a “hold” rating to a “sell” rating in a research note on Friday, October 3rd. Finally, William Blair started coverage on IperionX in a research report on Tuesday, January 13th. They set an “outperform” rating for the company. Three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, IperionX has an average rating of “Moderate Buy” and a consensus price target of $51.00.
View Our Latest Analysis on IPX
IperionX Trading Up 7.9%
Hedge Funds Weigh In On IperionX
Several institutional investors have recently bought and sold shares of IPX. Jane Street Group LLC increased its position in IperionX by 70.4% in the first quarter. Jane Street Group LLC now owns 31,967 shares of the company’s stock worth $575,000 after buying an additional 13,207 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of IperionX by 684.4% during the 2nd quarter. GAMMA Investing LLC now owns 957 shares of the company’s stock valued at $30,000 after buying an additional 835 shares during the last quarter. Atlantic Union Bankshares Corp bought a new position in shares of IperionX during the 2nd quarter worth $220,000. JPMorgan Chase & Co. purchased a new stake in IperionX in the 2nd quarter worth about $66,000. Finally, Thomist Capital Management LP purchased a new stake in IperionX in the 2nd quarter worth about $59,384,000. Hedge funds and other institutional investors own 2.76% of the company’s stock.
IperionX Company Profile
IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.
At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.
Further Reading
- Five stocks we like better than IperionX
- A month before the crash
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Wall Street Alert: Buy AES
- Bitcoin is down but your income is about to explode
- Trump Devises the Death of the IRS ☠️
Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.
